7SWX
SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-57 (three down conformation)
Entity
| Entity ID | Chain ID | Description | Type | Chain length | Formula weight | Number of molecules | DB Name (Accession) | Biological source | Descriptive keywords |
| 1 | A, B, C (A, B, C) | Spike glycoprotein | polymer | 1133 | 125519.1 | 3 | UniProt (P0DTC2) Pfam (PF16451) Pfam (PF09408) Pfam (PF19209) Pfam (PF01601) | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV SARS-CoV-2) | S glycoprotein,E2,Peplomer protein |
| 2 | D (H) | SARS2-57 Fv heavy chain | polymer | 117 | 12955.3 | 1 | Mus musculus (Mouse) | ||
| 3 | E (L) | SARS2-57 Fv light chain | polymer | 112 | 12383.8 | 1 | Mus musculus (Mouse) | ||
| 4 | AA, BA, CA, DA, EA... (a, b, c, d, e...) | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose | branched | 424.4 | 28 | In PDB GlyTouCan (G42666HT) | |||
| 5 | AB, BB, CB, DB, EB... (C, A, B) | 2-acetamido-2-deoxy-beta-D-glucopyranose | non-polymer | 221.2 | 25 | Chemie (NAG) |
Sequence modifications
A, B, C: 14 - 1146 (UniProt: P0DTC2)
| PDB | External Database | Details |
|---|---|---|
| Pro 817 | Phe 817 | engineered mutation |
| Pro 892 | Ala 892 | engineered mutation |
| Pro 899 | Ala 899 | engineered mutation |
| Pro 942 | Ala 942 | engineered mutation |
| Pro 986 | Lys 986 | engineered mutation |
| Pro 987 | Val 987 | engineered mutation |
Sequence viewer
Contents of the asymmetric unit
| Polymers | Number of chains | 5 |
| Total formula weight | 401896.5 | |
| Branched | Number of molecules | 28 |
| Total formula weight | 11883.2 | |
| Non-Polymers* | Number of molecules | 25 |
| Total formula weight | 5530.2 | |
| All* | Total formula weight | 419309.9 |
